On ECHEMI
Home > Drugs > Shandong Kelun Phaemaceutical Co., Ltd.
Shandong Kelun Phaemaceutical Co., Ltd.
  • Founded in:

    2004-03-12
  • Country:

    China China
  • Address:

    No. 12, Yongzheng Road, Xiaoying Town, Bincheng District, Binzhou City, Shandong Province
  • Tax NO.:

    91371600763665131C
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

Related Drugs
Metronidazole and glucose injection
This product is a compound preparation, its components are: metronidazole 0.2%, glucose 5%.
Name Description Content CAS NO. Registered Holders
Metronidazole

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. It has a strong killing effect on trichomonas, and its mechanism is unknown. It has a killing effect on anaerobic microorganisms. The metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death.

More

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. It has a strong killing effect on trichomonas, and its mechanism is unknown. It has a killing effect on anaerobic microorganisms. The metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death.

0.2% 443-48-1 39
GLUCOSE

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. Metronidazole is carcinogenic to some animals.

More

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. Metronidazole is carcinogenic to some animals.

5% 58367-01-4 14
Xanthinol Nicotinate Sodium Chloride Injection
Xanthinol Nicotinate
Name Description Content CAS NO. Registered Holders
Xanthinol nicotinate

This product is a vasodilator that can improve blood rheology and reduce peripheral vascular resistance. This product can promote glucose to pass through the blood-brain barrier, enhance the utilization of glucose and oxygen in brain cells, and improve brain sugar metabolism and brain function.

More

This product is a vasodilator that can improve blood rheology and reduce peripheral vascular resistance. This product can promote glucose to pass through the blood-brain barrier, enhance the utilization of glucose and oxygen in brain cells, and improve brain sugar metabolism and brain function.

437-74-1 9
Sodium Chloride Injection
The main ingredients of this product and its chemical name: Sodium chloride. Its structural formula is: NaCl. Molecular formula: NaCl. Molecular weight: 58.44
Name Description Content CAS NO. Registered Holders
Sodium chloride

Sodium chloride is an electrolyte supplement. Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining normal blood and extracellular fluid volume and osmotic pressure. The normal serum sodium concentration is 135-145mmol/L, accounting for 92% of plasma cations and 90% of total osmotic pressure, so the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum chloride concentration is 98-106mmol/L. Sodium and chloride ions in the human body are mainly regulated by the posterior lobe of the hypothalamus and pituitary and the kidneys to maintain the stability of body fluid volume and osmotic pressure.

More

Sodium chloride is an electrolyte supplement. Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining normal blood and extracellular fluid volume and osmotic pressure. The normal serum sodium concentration is 135-145mmol/L, accounting for 92% of plasma cations and 90% of total osmotic pressure, so the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum chloride concentration is 98-106mmol/L. Sodium and chloride ions in the human body are mainly regulated by the posterior lobe of the hypothalamus and pituitary and the kidneys to maintain the stability of body fluid volume and osmotic pressure.

7647-14-5 43
Ofloxacin Sodium Chloride Injection
The main ingredient of this product is ofloxacin. Its chemical name is (±)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-[1,4]benzoxazine-6-carboxylic acid.
Name Description Content CAS NO. Registered Holders
Ofloxacin

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial effect on most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good resistance to Chlamydia trachomatis, Mycoplasma and Legionella.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial effect on most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good resistance to Chlamydia trachomatis, Mycoplasma and Legionella.

82419-36-1 30
Glucose injection
The main component of this product is glucose. Its chemical name is D-(+)-pyranose glucose-hydrate.
Name Description Content CAS NO. Registered Holders
GLUCOSE

Caloric supplementation, treatment of hypoglycemia, used with insulin to treat hyperkalemia, rapid intravenous push of hypertonic glucose injection to dehydrate tissues, maintain and regulate the osmotic pressure of peritoneal dialysis fluid

More

Caloric supplementation, treatment of hypoglycemia, used with insulin to treat hyperkalemia, rapid intravenous push of hypertonic glucose injection to dehydrate tissues, maintain and regulate the osmotic pressure of peritoneal dialysis fluid

58367-01-4 14
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.